Conventional measures underestimate glycaemia in cystic fibrosis patients
Aims Diabetes mellitus is an increasingly important complication of cystic fibrosis (CF). The association with increased morbidity of cystic fibrosis‐related diabetes (CFRD) has emphasized the need for accurate monitoring of glycaemia in all CF patients. The diagnosis has relied on conventional thresholds in an oral glucose tolerance test (OGTT) derived from epidemiological studies in non‐CF subjects. However, it has not been established if these values are equivalent in CF and non‐CF populations.
No Supplementary Data
No Article Media
Document Type: Research Article
Affiliations: 1: Department of Respiratory Medicine, Royal Devon and Exeter Hospital and 2: Diabetes and Vascular Medicine, Peninsular Medical School, Exeter, UK
Publication date: 01 July 2004